p.125 抽出テキスト

pain. Curr Med Res Opin 2003;19:457‒69 66) Wong JO, Chiu GL, Tsao CJ, et al. Comparison of oral controlled‒release morphine with transdermal fentanyl in terminal cancer pain. Acta Anaesthesiol Sin 1997;35:25‒32 67) Kjaer M, Henriksen H, Knudsen J. A comparative study of intramuscular buprenorphine and morphine in the treatment of chronic pain of malignant origin. Br J Clin Pharmacol 1982;13: 487‒92 68) Pasqualucci V, Tantucci C, Paoletti F, et al. Buprenorphine vs. morphine via the epidural route:a controlled comparative clinical study of respiratory effects and analgesic activity. Pain 1987;29:273‒86 69) Pace MC, Passavanti MB, Grella E, Buprenorphine in long‒term control of chronic pain in cancer patients. Front Biosci 2007;12:1291‒9 70) Wang J, Cai B, Huang DX, et al. Decreased analgesic effect of morphine, but not buprenorphine, in patients with advanced P‒glycoprotein(+)cancers. Pharmacol Rep 2012;64:870‒7 71) Choudhury K, Dasgupta P, Paul N, et al. A comparative study of transdermal buprenorphine and oral morphine in the treatment of chronic pain of malignant origin. Indian J Palliat Care 2018;24:500‒4 72) Hanna M, Thipphawong J;118 Study Group. A randomized, double‒blind comparison of OROS® hydromorphone and controlled‒release morphine for the control of chronic cancer pain. BMC Palliat Care 2008;7:17 73) Wirz S, Wartenberg HC, Nadstawek J. Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open‒labeled investigation on cancer pain. Support Care Cancer 2008;16:999‒1009 74) Moriarty M, McDonald CJ, Miller AJ. A randomised crossover comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain. J Clin Res 1999;2:1‒8 75) Beaver WT, Wallenstein SL, Houde RW, et al. A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone. Clin Pharmacol Ther 1967;8:415‒26 76) Bruera E, Palmer JL, Bosnjak S, et al. Methadone versus morphine as a first‒line strong opioid for cancer pain:a randomized, double‒blind study. J Clin Oncol 2004;22:185‒92 77) Ventafridda V, Ripamonti C, Bianchi M, et al. A randomized study on oral administration of

morphine and methadone in the treatment of cancer pain. J Pain Symptom Manage 1986;1: 203‒7

【参考文献】a) Wiffen PJ, Wee B, Moore RA. Oral morphine for cancer pain. Cochrane Database Syst Rev 2016;4:CD003868 b) Wiffen PJ, Derry S, Moore RA. Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain. Cochrane Database Syst Rev 2014;5:CD011056 c) Wiffen PJ, Wee B, Derry S, et al. Opioids for cancer pain ‒ an overview of Cochrane reviews.

Cochrane Database Syst Rev 2017;7:CD012592